Jito Staked SOL vs Injective Staking
Side-by-side comparison of JITOSOL and INJ staking yields, risk, and key metrics. Updated every 4 hours.
Detailed comparison
Jito Staked SOL vs Injective: which should you stake?
Injective currently offers the higher APY at 6.39% compared to Jito Staked SOL's 5.80%. That's a 0.59 percentage point difference in annual yield.
In terms of market cap, Jito Staked SOL is the larger asset at $930.91M, which generally indicates more liquidity and lower volatility risk.
Both assets can be staked through various platforms and protocols. Consider diversifying across both rather than choosing one exclusively — this spreads your risk across different networks and ecosystems.
Jito Staked SOL vs Injective — common questions
Is Jito Staked SOL or Injective better for staking?
Injective currently offers a higher staking APY at 6.39% compared to Jito Staked SOL's 5.80%. However, the best choice depends on your risk tolerance, investment horizon, and portfolio strategy.
What is the APY difference between Jito Staked SOL and Injective?
Jito Staked SOL offers 5.80% APY while Injective offers 6.39% APY — a difference of 0.59 percentage points.
Which is safer to stake: JITOSOL or INJ?
Jito Staked SOL has a medium risk rating while Injective has a medium risk rating. Lower risk typically means a more established network with stronger validator infrastructure.
Can I stake both JITOSOL and INJ?
Yes, diversifying across multiple staking assets is a common strategy. Staking both Jito Staked SOL and Injective spreads your risk across different networks and protocols.